Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Abstract Background Successful eradication of hepatitis C virus (HCV) has great impact on the prognosis of HCV-related complications and the associated mortality. The development of the new direct-acting antiviral drugs (DAAs) has revolutionized the treatment of HCV infection. HCV core antigen (HCVc...

Full description

Bibliographic Details
Main Authors: Asmaa M. Elbrolosy, Moamena S. Elhamouly, Emad M. Eed, Gamalat A. El Gedawy, Mai Abozeid, Naglaa S. Elabd
Format: Article
Language:English
Published: SpringerOpen 2021-03-01
Series:Egyptian Liver Journal
Subjects:
HCV core antigen
HCV RNA assay
New direct-acting antiviral drugs
Online Access:https://doi.org/10.1186/s43066-021-00092-w

Internet

https://doi.org/10.1186/s43066-021-00092-w

Similar Items